IDSA Daily News Briefing - Briefing. FDA Withdraws Emergency Use Authorization of Hydroxychroroquine and Chloroquine as Treatment in Patients with COVID-19.
Gertie Chimeka Anyanwoke 17 Jun 2020 09:39 CDT
https://idsa.bulletinhealthcare.com/?tokenid=d9103316n6uze9mqm79s3p7955277uze9mqm79s3p8p630&dt=20200617&d=2020-06-16&a=S1
Sent from my iPhone